Tempest Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Kolkata, West Bengal, India, established in 2007.
2007 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Tempest Pharmaceuticals Private Limited

Tempest Pharmaceuticals Private Limited, a active private limited company, was established on 25 May 2007 in Kolkata, West Bengal, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232WB2007PTC116075. Registered under ROC Roc Kolkata I. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

Its leadership includes Buddhadeb Chakraborty (Director), Rishab Jaiswal (Director). Past directors included Mukesh Shaw, Kanhaiya Kumar. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor 124, Dakshin Para Road, Kolkata, West Bengal, 700028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232WB2007PTC116075

  • Registration Number

    116075

  • Incorporation Date

    25 May 2007

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Kolkata I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 19 Year, 16 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Tempest Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Tempest Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tempest Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Buddhadeb Chakraborty Director 10 Jun 2023 Current
Rishab Jaiswal Director 10 Jun 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Jun 2023 Past
Pramod Abcsdd Director 26 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tempest Pharmaceuticals.

Enhance accessibility to Tempest Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Tempest Pharmaceuticals revenue growth over time
Tempest Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tempest Pharmaceuticals?

In 2016, Tempest Pharmaceuticals had a promoter holding of 4.00% and a public holding of 96.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tempest Pharmaceuticals?

Unlock and access historical data on people associated with Tempest Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tempest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tempest Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tempest Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Tempest Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Tempest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I. was recorded as a recent event.

  • Director Appointment

    Buddhadeb Chakraborty was appointed as a Director was appointed as a Director on 10 Jun 2023 & has been associated with this company since 3 years . was recorded as a recent event.

  • Director Appointment

    The activity Rishab Jaiswal was appointed as a Director was appointed as a Director on 10 Jun 2023 & has been associated with this company since 3 years . was completed.

  • Company Incorporation

    Progress on Tempest Pharmaceuticals Private Limited was registered on 25 May 2007 with Roc Kolkata I & aged 19 years 16 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tempest Pharmaceuticals Private Limited?

The CIN of Tempest Pharmaceuticals Private Limited is U24232WB2007PTC116075.

Where is Tempest Pharmaceuticals Private Limited headquartered?

Tempest Pharmaceuticals Private Limited is headquartered at Ground Floor 124, Dakshin Para Road, Kolkata, West Bengal, 700028.

When was Tempest Pharmaceuticals Private Limited incorporated?

Tempest Pharmaceuticals Private Limited was incorporated on 25 May 2007.

Who are the current directors of Tempest Pharmaceuticals Private Limited?

The current directors of Tempest Pharmaceuticals Private Limited are

What is the primary industry of Tempest Pharmaceuticals Private Limited?

The primary industry of Tempest Pharmaceuticals Private Limited is Chemicals.

Is Tempest Pharmaceuticals Private Limited a listed company?

Tempest Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Tempest Pharmaceuticals Private Limited?

The authorized capital of Tempest Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available